RVXOT
Thanks for that
Patients are being dosed and the clock is ticking. Open label trial could leak results prematurely. He also stated that a financing update was forthcoming - which I would expect to happen well before the debenture due date. I'm sure there is a lot going on behind the curtain.
Will we have a rising sun or a setting sun?